For US residents only

Get the inside story on TYKERB

TYKERB + capecitabine can be used for HER2+ metastatic breast cancer
after progression on Herceptin®, an anthracycline, and a taxane

Important Safety Information, including Boxed WARNING:

Some people may develop liver damage while taking TYKERB® (lapatinib). Liver problems can be severe and deaths have happened. Before taking TYKERB, tell your ...

See More
Approved Use:

TYKERB is used with a medicine called capecitabine (brand name Xeloda®) for the treatment of people with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and Herceptin® (trastuzumab). Tumor...

See More
learn more about

TYKERB + capecitabine

TYKERB is used with a medicine called capecitabine (brand name Xeloda®) for the treatment of people with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and Herceptin® (trastuzumab). Tumors that are HER2 positive make a large amount of a protein called human epidermal growth factor receptor-2.

Learn More
learn more about

Support for patients taking TYKERB

Novartis Oncology is committed to helping you receive the medicines and support you need throughout your treatment. A variety of resources are available, including educational materials, financial assistance, and treatment management tools.

Learn More